Barclays PLC Raises Position in Arteris, Inc. (NASDAQ:AIP)

Barclays PLC raised its holdings in shares of Arteris, Inc. (NASDAQ:AIP) by 321.1% in the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 39,396 shares of the company’s stock after acquiring an additional 30,041 shares during the period. Barclays PLC’s holdings in Arteris were worth $304,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Bank of New York Mellon Corp purchased a new stake in Arteris during the 2nd quarter valued at about $580,000. Rhumbline Advisers lifted its position in Arteris by 2,182.8% in the second quarter. Rhumbline Advisers now owns 31,822 shares of the company’s stock valued at $239,000 after purchasing an additional 30,428 shares during the last quarter. Renaissance Technologies LLC boosted its stake in shares of Arteris by 6.1% during the second quarter. Renaissance Technologies LLC now owns 114,700 shares of the company’s stock valued at $861,000 after purchasing an additional 6,600 shares during the period. CloudAlpha Capital Management Limited Hong Kong bought a new position in shares of Arteris in the second quarter worth approximately $554,000. Finally, The Manufacturers Life Insurance Company purchased a new position in shares of Arteris in the second quarter worth $86,000. 64.36% of the stock is owned by institutional investors.

Insider Activity at Arteris

In related news, Director Saiyed Atiq Raza sold 12,166 shares of the stock in a transaction dated Wednesday, December 18th. The shares were sold at an average price of $10.07, for a total value of $122,511.62. Following the completion of the transaction, the director now directly owns 731,560 shares of the company’s stock, valued at $7,366,809.20. This represents a 1.64 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CEO K Charles Janac sold 17,856 shares of Arteris stock in a transaction that occurred on Thursday, December 12th. The shares were sold at an average price of $10.12, for a total value of $180,702.72. Following the sale, the chief executive officer now directly owns 10,287,435 shares in the company, valued at approximately $104,108,842.20. The trade was a 0.17 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 254,222 shares of company stock worth $2,537,693 over the last quarter. Corporate insiders own 33.70% of the company’s stock.

Wall Street Analyst Weigh In

Separately, Rosenblatt Securities reissued a “buy” rating and set a $15.00 price target on shares of Arteris in a research report on Wednesday, November 6th.

Arteris Price Performance

Shares of AIP stock opened at $12.25 on Friday. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.16 and a current ratio of 1.16. The firm has a market cap of $492.17 million, a P/E ratio of -12.76 and a beta of 1.25. The business’s 50 day moving average price is $8.89 and its 200-day moving average price is $8.05. Arteris, Inc. has a fifty-two week low of $4.83 and a fifty-two week high of $12.39.

About Arteris

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.